- Home
- TKLF vs ADIL Comparison
TKLF vs ADIL Comparison
Compare TKLF & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKLF | ADIL |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 7.3M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TKLF | ADIL |
|---|---|---|
| Price | $1.75 | $6.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | 13.9K | ★ 73.5K |
| Earning Date | 12-19-2025 | 05-13-2026 |
| Dividend Yield | ★ 10.97% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.69 | $0.13 |
| 52 Week High | $4.32 | $5.94 |
Technical Indicators
Market Signals| Indicator | TKLF | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 38.12 | 78.62 |
| Support Level | $1.78 | $1.63 |
| Resistance Level | $2.39 | N/A |
| Average True Range (ATR) | 0.09 | 0.60 |
| MACD | -0.02 | 0.19 |
| Stochastic Oscillator | 25.01 | 100.00 |
Price Performance
Historical ComparisonAbout TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.